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Abstract
The levels of malondialdehyde (MDA) are high in the brain during carbonyl stress, such as following daily activities and sleep
deprivation. To examine our hypothesis that MDA is one of the major substances in the brain leading to fatigue, the
influences of MDA on brain functions and neuronal encodings in red-eared turtle (Trachemys scripta) were studied. The
intrathecal injections of MDA brought about sleep-like EEG and fatigue-like behaviors in a dose-dependent manner. These
changes were found associated with the deterioration of encoding action potentials in cortical neurons. In addition, MDA
increased the ratio of c-aminobutyric acid to glutamate in turtle’s brain, as well as the sensitivity of GABAergic neurons to
inputs compared to excitatory neurons. Therefore, MDA, as a metabolic product in the brain, may weaken cerebral function
during carbonyl stress through breaking the homeostasis between excitatory and inhibitory neurons.
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Introduction
Numerous studies have demonstrated that oxidation and
glycation stresses are key causal factors of aging-related chronic
diseases and neuronal degenerative diseases [1,2,3,4,5]. These
stresses inevitably produce a variety of toxic intermediates, mainly
unsaturated carbonyls, such as malondialdehyde (MDA) and
formaldehyde (FA) [6], which usually cause carbonyl-amino
crosslinking and eventually lead to the accumulation of irreversible
pathophysiological changes (like lipofuscin) in the central nerve
system (CNS) [7,8,9,10]. The toxicity of such unsaturated
carbonyls has been suggested as the important cause of aging-
related biochemical alterations of animal and human body
including brain degeneration [11,12,13,14,15]. Not only related
with aging and diseases, the levels of toxic carbonyls have also
been found largely increased following daily activities, particularly
after intense exercise or sleep deprivation [8,16].
Unsaturated carbonyls, like malondialdehyde (MDA) being less
active than free radicals, often have a relatively longer half-life
and, thereby, may diffuse from the places of generation to other
sites in vivo, bringing further oxidative/carbonyl stresses. MDA, as
one of the most important intermediates of free radical damages
[8,17], can readily and widely bind or crosslink important
biological macromolecules such as proteins and nucleic acids
[8,18]. Such carbonyl stress-related reactions, or in simple,
carbonylation, can form unstable 1:1 amino-carbonyl compounds
at an early stage and form versatile stabilized protein complex later
[8,10]. Although the early stage carbonylation can be actively
reversed by several biological defense systems, the accumulation
process of amino-carbonyl reaction continues, following daily
activity or stresses [19,20]. Therefore studies on the effects of
carbonylation on the cerebral suppression and its relation to brain
degeneration with respect of neuronal functions are of great
interest and importance.
Although much work on carbonyl stress related to damage of
animal brain has been reported, the effect of MDA on the turtle’s
cerebral activity is not reported. For instance, the LD50 of MDA
for mouse is about 400 pmol/mouse (2 g/kg), suggesting that this
compound is seriously toxic to mammals [21]. As we know, the
turtle’s brain appears to have stronger mechanisms to protect
against the damages of reactive oxygen species than mice [22,23].
Furthermore, turtle is able to resist to a relatively higher
concentration of MDA administrated than mammals during the
experiments [24]. This gives us a chance to observe the effect of a
wide concentration range of MDA on the brain activities [25]. As
far as it goes, the reports about the influence of carbonyls on the
cerebral activities of the turtle have not been found, thus the turtle
(T. scripta elegans) was employed in this investigation.
In this laboratory, as described previously, free radical damage
to lipids resulted in malondialdehyde reacting with a protein and
releasing an intermediate product of formaldehyde [26]. Formal-
dehyde at low concentrations induced protein misfolding to
produce a high cytotoxic aggregation [6]. In this paper, we
introduce turtle as a new model to study the effects of carbonyl
stress induced by MDA on the CNS because this animal has the
ability to be resistant to high levels of MDA.
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Animals
Female 2-year-old red-eared turtles (T. scripta elegans) weighing
between 900 and 1100 g (Changsha, China) were subject to the
experiments. All animals were randomly assigned to eleven
fiberglass tanks (0.860.460.5 m), which contained fresh water
and a dry platform for thermal regulation. For acclimatization,
they were housed in the experimental room for at least one week
before study. Turtles were kept under the standard conditions with
12:12 h light/dark cycles and at an ambient temperature of
2361uC. Food was continuously available.
For EEG recordings, 20 turtles were randomly divided into 4
groups, whereas one group (5 turtles) was treated with control
solution and other three groups (15 turtles) were treated with
different concentrations of MDA. Thirty-six turtles were used for
the assay of MDA concentration in turtles’ brain. Thirty-six turtles
were used for HPLC analyses to detect the changes of the GABA
and Glu content in turtles’ brain. Eighteen turtles were used for
the whole-cell recordings. All experimental procedures were
carried out according to regulations on the care and treatment
of laboratory animals claimed by the Chinese Academy of
Sciences. This study was approved by Bio-safety Committee and
Animal Ethics Committee of Institute of Biophysics, Chinese
Academy of Sciences (approval ID SYXK-125).
Surgery
For intrathecal treatment of chemicals, a vertical hole (2.5 mm
in diameter, 5–9 mm deep) at the center of backbone on the first
median-back scale of the turtles was made with a sterilized tooth-
drill. A small plastic catheter (1.5 mm in diameter, 10 cm long)
connecting with a syringe (Kang-kang Medical Instrument Co.
Ltd., Yuhuan, China) was inserted into the spinal cavity and fixed
with dental cement. After the surgical procedures, the turtles were
kept to recover for 3 days before the experiment.
Preparation of MDA and control solution
MDA stock solution (200 mM, 4.05% w/w, the highest
practical concentration to avoid possible self-polymerization of
MDA under the experimental conditions) was freshly prepared by
hydrolyzing 1,1,3,3-tetramethoxypropane (TMP) (purity$98%,
Fluka Chemie AG, Buchs, Switzerland), which was modified
according to the method as described [19,27,28]. Namely, 338 ml
TMP was mixed with 1.5 ml 1 M HCl, and shaken at 40uCt o
obtain MDA through acidic hydrolysis. After the solution became
homogeneous, indicating a successful hydrolization of TMP, the
acidity of solution was carefully neutralized to pH 7.2 with 6 M
NaOH and made up to 10 ml with ultra pure water. Diluted with
0.10 M phosphate buffer, MDA working solutions (final
concentrations, 0.2 mM, 2 mM and 20 mM) were injected
(100 ml/kilogram) into spinal cavity injection. The control solution
was prepared by substituting TMP with the saline solution (1 M
HCl, 6 M NaOH, pH 7.2, 10 ml).
EEG recordings and behavioral observations
Quantified EEG analysis is a sensitive and reproducible
technique in assessing the effects of drugs acting on CNS during
sleep-wake cycles [29,30,31]. The EEG signals were measured
with KT88-AV2000 BEAM System (Contec Medical Systems Co.
Ltd., Alhambra, USA). Stainless steel needles (0.1 mm in
diameter, Suzhou Medical Appliance Factory, Suzhou, China)
were used as electrodes to detect the EEG signals. One electrode
was inserted into the nasion as a reference electrode and other two
electrodes were symmetrically inserted into the right and left
occipital regions of the skull (3 mm lateral and 3 mm anterior to
the lambda).
The EEG of turtles was recorded for 30 and 40 minutes
separately before and after MDA treatment. The speed of MDA
infusion was maintained at 0.10 ml/kg/5 minutes. During EEG
recordings, the turtles were fixed on an experimental platform with
cellulose tapes and isolated in an observable cabin with ventilation
system. The room temperature was maintained at about 2361uC.
EEG signals were amplified and converted into digital signals by
means of a multi-channel A-D converter and processed for fast
Fourier transform spectral analysis. The sampling rate for EEG
was 128 Hz and the signals were bandpass-filtered between 1.0
and 30.0 Hz before analysis. EEG amplitude was 50 mV/cm. The
EEG power density in four frequency bands, delta (1.0–4.0 Hz),
theta (4.0–8.0 Hz), alpha (8.0–13.0 Hz) and beta (13.5–30.0 Hz)
waves, was calculated from data of 5 turtles, whereas spectral data
of 3 individual epochs (30 s for each epoch) were obtained from
each turtle (epochs containing artifacts were omitted).
Heart rate was recorded from inserting an additional electrode
into left posterior leg of the turtle. The behavior of the whole
animals was closely observed. To judge the vigilance states of
turtles, the threshold of turtle’s reaction to stimuli was checked by
sticking the left posterior leg of the turtle with a needle (the needle-
stick test). The needle-stick test was performed at every 10 minutes
after MDA treatment.
The assay of MDA concentration in turtles’ brain
The turtle brain was homogenated by a homogenizer with 9
folds 0.86% NaCl on a glacial board. The cerebral homogenates
were centrifuged (2000 rpm, 4uC, 15 minutes). The supernatant
fluid (the cerebral extract) was used for the assay of MDA
concentration. The method was as described by Kikugawa and
coworkers [32].
Whole-cell recordings
Cerebral slices (400 mm) were prepared from red-eared turtles
that were decapitated quickly with a guillotine. Cerebral slices
were cut with Vibratome in the oxygenated (95% O2 and 5%
CO2) artificial cerebrospinal fluid (ACSF, mM: 100 NaCl, 3.5
KCl, 1.25 NaH2PO4, 26 NaHCO3, 2 CaCl2, 2 MgSO4, and 2
glucose, pH 7.4) at 40uC. The slices were held in ACSF at 25uC
for 1–2 hours. A slice was transferred to a submersion chamber
(Warner RC-26G) that was perfused with the oxygenated ACSF at
31uC for whole-cell recording as described [33]. Chemicals were
from Sigma. The procedures were approved by IACUC in
Beijing, China.
Pyramidal neurons show pyramidal-like soma and an apical
dendrite, and interneurons are round with multipolar processes
under DIC optics (Nikon FN-E600, Japan). Pyramidal neurons
and interneurons show the different properties in the response to
the hyperpolarization and depolarization pulses, especially spike
patterns.
The recordings were conducted in current-clamp model with an
Axoclamp-2B amplifier (Axon Instrument Inc., Foster CA, USA),
and electrical signals were inputted into pClamp 10 (Axon
Instrument, Inc, Foster CA, USA) for data acquisition and
analysis. Output bandwidth in amplifiers was 3 kHz. The spike
patterns were evoked by depolarization current pulses, in which
the amplitude and duration were based on the aim of experiments.
Pipettes for whole-cell recordings were filled with the standard
solution that contained (mM) 150 K-gluconate, 5 NaCl, 5 HEPES,
0.4 EGTA, 4 Mg-ATP, 0.5 Tris-GTP and 5 phosphocreatine
(pH 7.35 adjusted by 2 M KOH). Fresh pipette solution was
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osmolarity was 295-305 mOsmol. Pipette resistance was 5–6 MV.
Inter-spike intervals (ISI) are used to define spike capacity at
threshold stimulus. A small ISI indicates that the cells can fire
more spikes in a given time. ISI or the standard deviation of spike
timing (SDST) of sequential spikes is linearly correlated with
absolute refractory period (ARP) or threshold potential
(DVts=Vts-Vr), indicating that ARP and DVts control the
capacity of sequential spikes. We examine whether MDA affects
ISI and SDST of sequential spikes at pyramidal neurons and
interneurons through changing ARP and DVts.
The intrinsic properties of cerebral pyramidal neurons and
interneurons in our investigation include the threshold potentials
for initiating spikes and refractory periods following each of spikes.
The threshold potentials are a start point of the rising phase of
spikes [33]. The ARP of sequential spikes are measured by
injecting multiple depolarization current pulses (3 ms and 5%
above threshold levels) into the neurons following each of spikes.
By changing inter-pulse intervals, we define ARP as duration from
a complete spike to a subsequent spike at 50% probability [33].
Spike capacity is represented as ISI.
HPLC of cerebral neurotransmitters in turtles’ brain
The standard solution of GABA or Glu (1 mM) was mixed with
water-methanol (1:1) and stored at 4uC. The standard stock
solutions were freshly diluted with Ringer solution as described
previously [34].
The turtles were decapitated at different time intervals (5 and 35
minutes) after MDA or control treatment. Their brains were
quickly taken out, and homogenated by a homogenizer with
methanol on a glacial table. The cerebral homogenates were
sonicated, and then centrifuged (12000 rpm, 4uC, 20 minutes).
The supernatant fluid (the cerebral extract) was used for HPLC.
o-Phthalaldehyde (OPA, 25 mg) was dissolved in 0.4 M borate
buffer (5 ml, pH 9.6) containing 0.5 ml methanol anhydrous and
40 ml b-mercaptoethanol before use. The derivatization was
carried out by adding the OPA solution (30 ml) to the standard
amino acid solution or the cerebral extract of turtle brain at
equivalent volume (reaction time, 1.5 minutes). After that, 50 mlo f
the reacted sample was taken for HPLC.
The sample was injected into a Venusil MP ODS column
(25064.6 mm I.D., 5 mm particle size, Agela Technolodies Inc,
Newark, USA) to run the gradient elution by a pump (Hitachi
7100, Japan) and monitored (338 nm, 37uC) by an ultraviolet
detector (Hitachi 7420, Japan). At pH 7.2 (adjusted with acetic
acid), mobile phase A (1000 ml) containing 2.72 g sodium acetate
anhydrous/0.2 ml triethylamine and mobile phase B containing
1.35% (w/w) sodium acetate anhydrous-acetonitrile-methanol
(4:7:9, v/v) were filtered through a 0.22 mm polyamide membrane
filter and degassed with the ultrasonication (SB-5200 ultrasonic
cleaner, Xin-zhi Biological Instrument Co. Ltd., Ningbo, China)
for 10 minutes. The derivative product was separated with the
gradient elution with the mixture of the mobile phase A+Ba s
indicated with the volume proportion of the mobile phase B: 4
minutes from 0.5% to 26%, 4 minutes at 26%, 7 minutes from
26% to 100%, and finally another 7 minutes at 100%.
Statistical analysis
Data of EEG recordings and HPLC analysis were analyzed and
showed in means 6 standard deviation (S.D.). Student t-test was
used to compare mean values of EEG power density, HPLC peak
area of Glu and GABA and the ratio of them, and the MDA
concentration in order to assess the statistical significance of the
changes. Data of whole-cell recordings were analyzed when the
recorded neurons had the resting membrane potentials negatively
more than 255 mV. The criteria for the acceptation of each
experiment also included less than 5% changes in resting
membrane potential, spike magnitude, input resistance and seal
resistance throughout each of experiments. Input resistance was
monitored by measuring cell responses to the hyperpolarization
pulses at the same values as the depolarization that evoked spikes.
DVts, ARP and ISI are presented as mean 6 SE. The
comparisons between groups are done by paired t-test. The
statistical analysis was performed using the software package
Origin, version 8.0 for Windows.
Results
EEG recordings and behavior changes
Before MDA treatment, the turtles’ heads lifted, and their eyes
opened. They occasionally moved their heads and legs, with
intense muscular activities. The threshold for the reaction to
stimuli was low, showing a quick retraction of heads and legs into
the shell. Under this condition, the EEG was characterized by a
pattern of high frequency and low amplitude (control in Fig. 1).
Malondialdehyde (final concentration, 2 mM/kg body weight)
was intrathecally injected into the spinal cavity of the turtle, and
slow waves with high amplitude appeared after a latency of 5–8
minutes (Fig. 1). This state maintained for about 1 h and then the
EEG approached to the basal state. Note that the heart rates (24
beats/min on average) of the turtles did not show statistically
significant changes. Under 2 mM MDA treatment, the eyelids and
heads of turtles were not observed to hang down distinguishably.
Their reaction threshold remained relatively low and the animals
responded (retracting heads and legs) quickly to stimuli. To
confirm the effect of 2 mM MDA treatment on turtles, MDA
treatment (0.2 mM/kg) was carried out. Neither the EEG signals
nor the heart rates including the behavior of turtles showed
significant changes compared to control group.
In order to see a strong effect of MDA on the behavior and
EEG, a high MDA concentration treatment was performed.
Similar but stronger EEG changes were observed when turtles
were treated with 20 mM/kg MDA than that with 2 mM MDA
(Fig. 1). The intrathecal treatment of 20 mM/kg MDA induced,
with a latency of 3–5 minutes, an almost complete suppression of
EEG signal with irregular spike waves. This period lasted for 2–3
minutes on average. Subsequent EEG tracings were characterized
by slow waves that gradually increased in amplitude to reach
values remarkably higher than basal waves as control. Quantified
EEG analysis revealed statistically significant changes of power
density in all 4 frequency bands (Tab. 1 and Fig. 2). The heart
rates after 20 mM MDA treatment (16 beats/minutes on average,
also showed a significant change, compared with those before the
treatment (24 beats/minutes on average). Under 20 mM MDA
treatment, some turtles rested their heads on the experimental
platform, with relaxed necks, closed eyes, and extended legs out of
their shells. Their reaction threshold to stimuli was remarkably
increased after the treatment. These results indicate that the
carbonyl stress significantly affect the cerebral activity of the turtles
in a concentration dependent manner, suggesting a suppression of
the animal related to MDA.
MDA concentration in turtles’ brain after administration
To confirm the suppression in the presence of MDA, changes of
the MDA concentration in the turtle’s brain was detected.
Changes in the MDA concentrations in the turtles’ brain (5
minutes and 35 minutes) were observed (the EEG had also
significant changes as mentioned above). As shown in Tab. 2, the
MDA and Turtle Cerebral Suppression
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20 mM treatment are statistically higher than those of control
group and 0.2 mM group (p,0.001). This is to say, the MDA
diffused into the turtle’s brain from the spinal cavity and the MDA
level became higher than the normal level after 5 minutes of the
injection. The MDA level was markedly increased around 35
minutes.
MDA deteriorates neuronal encodings in the brain of the
red-eared turtles
To understand cellular mechanisms underlying MDA-induced
sleep-like EEG and fatigue-like behaviors, we examined the
influences of MDA on spike encodings in cortical neurons. Whole-
cell patch clamp was conducted at pyramidal neurons and fast-
spiking interneurons in cortical slices of turtles, and MDA (20 mM)
Figure 1. Effects of different concentrations of MDA on the EEG
signals of turtles. Typical EEG spectra of turtles treated with different
concentrations of MDA (0.1 ml/kg body weight) at different time
intervals were as indicated. The EEG signals of turtles without MDA
treatment were used as control.
doi:10.1371/journal.pone.0015325.g001
Table 1. Statistical significance of the changes in power
density after 20 mM/Kg MDA treatment versus basal
condition. (n=15).
Time(min) Delta band Theta band Alpha band Beta band
5 n.s. n.s. n.s. n.s.
10 P,0.001 P,0.001 P,0.05 P,0.05
15 P,0.001 P,0.001 P,0.001 P,0.001
20 P,0.001 P,0.001 P,0.001 P,0.001
25 P,0.001 P,0.001 P,0.001 P,0.001
30 P,0.001 P,0.001 P,0.001 P,0.001
35 P,0.001 P,0.001 P,0.001 P,0.001
doi:10.1371/journal.pone.0015325.t001
Figure 2. Quantified EEG power density analysis before and
under the MDA treatment. The time course of EEG power density of
different frequency was monitored under 20 mM MDA treatment (panel
a) and that of control (panel b). Data were means from 15 turtles
(n=15), respectively. The statistic data are shown in Tab. 1.
doi:10.1371/journal.pone.0015325.g002
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MDA increased ISI of sequential spikes in pyramidal neurons and
interneurons, especially in interneurons (Fig. 3; Table S1). As
inter-spike intervals are mainly controlled by refractory periods
[33], we tested if MDA prolonged ARP. The measurements of
ARP were done by giving multiple pulses (Methods for details;
Table S2). These results indicate that MDA attenuates the
capacity of encoding sequential spikes through the prolongation
of absolute refractory periods (Fig. 4).
MDA breaks homeostasis between excitation and
inhibition in brain networks
In terms of the mechanisms underlying the brain dysfunctions by
MDA-mediated carbonyl stress, we examined whether MDA results
in imbalance between glutamate and GABA activities in the brain of
red-eared turtles. As glutamate and GABA are released from cortical
pyramidal neurons and interneurons, respectively, an essential
solution to this hypothesis includes the measurements in the levels
of glutamate and GABA, as well as the sensitivities of pyramidal
neurons and interneurons to the inputs while giving MDA.
The sensitivities of these neurons to excitatory inputs were
measured based on the threshold potentials of sequential spikes.
Figure 4 shows that MDA (20 mM) reduced threshold potentials
(Vts) in pyramidal neurons and interneurons, but the change was
more prominent in interneurons than in pyramidal neurons (Table
S3). We also compared the changes in cellular sensitivity of
interneurons vs. pyramidal neurons, in which the changes in
threshold potentials (DVts) were calculated, i.e., threshold
potentials under the condition of MDA treatments were divided
by those under controls. Figure 4d shows DVts before and after
MDA treatment at interneurons and pyramidal neurons indicating
that an increase in the sensitivity of interneurons is more dominant
than that of pyramidal neurons by MDA treatment (Table S4).
This result well explains the role of MDA in inducing more GABA
in brain tissues as follows.
Changes in neurotransmitters during MDA treatment
To investigate the relation between the neurotransmitters and
EEG suppression, changes in the Glu and GABA levels in the
CNS during MDA treatment were detected using HPLC. The two
time points (5 minutes and 35 minutes), at which the EEG showed
significant changes, were chosen.
Glu and GABA in a standard mixture of amino acids were
clearly separated within 24 minutes. The retention time for Glu
Table 2. MDA concentration in turtle brain at 5 min and
35 min after MDA or control treatment. (Means6SD, n=3)
(Unit= mM/Kg).
Time(min) 20 mM MDA 2 mM MDA 0.2 mM MDA control
5 3.5460.83 3.3660.87 2.9760.78 3.5760.84
35 48.0966.64* 37.7966.35* 3.3760.92 3.3460.77
*p,0.001 vs control.
doi:10.1371/journal.pone.0015325.t002
Figure 3. The comparison of inter-spike intervals (ISI) and the standard deviation of spike timing (SDST). ISI and SDST of pyramidal
neurons (PN) and interneurons (IN) before and after 20 mM MDA treatments as indicated (* p,0.05, **p,0.01).
doi:10.1371/journal.pone.0015325.g003
MDA and Turtle Cerebral Suppression
PLoS ONE | www.plosone.org 5 December 2010 | Volume 5 | Issue 12 | e15325and GABA was about 15.8 minutes and 21.3 minutes, respectively
(Fig. 5). The HPLC peak areas of GABA and Glu in the extract of
turtle brain did not show significant changes in 5 minutes under
20 mM MDA treatment (Fig. 5a) compared to control group
(Fig. 5e). In 35 minutes under the MDA treatment, corresponding
to the strongest moment of slow wave EEG, the peak areas of both
GABA and Glu showed statistical increment (p,0.01) (Fig. 5b,
Tab. 3). The peak area of GABA increased much faster than that
of Glu, thus the ratio between GABA and Glu increased
significantly (p,0.01) (Fig. 5f). The turtles treated with 2 mM
MDA showed a similar change but weaker than the 20 mM MDA
treatment (Fig. 5c). However, the group treated with 0.2 mM
MDA showed no statistical changes (Fig. 5d) compared to the
control group (Tab. 3).
Discussion
Turtles, as mentioned above, showed fatigue-like behavior after
MDA administration. To explain primarily this characteristic
behavior, we carried out (1) EEG of the red-eared turtles during
the MDA treatment; (2) whole-cell recordings of brain slices; (3)
examination of the actual MDA concentration in the turtle brain,
and (4) analysis of the neurotransmitters by HPLC. Integrating
with these experimental results, we attempted to figure out the
relationship between the MDA and the CNS suppression under
our experimental conditions.
As described previously [35,36,37], the EEG patterns exhibited
by the chelonian reptiles are different from those in mammals
during their sleep-wakefulness cycle [38]. But some studies show
that the dorsal part of turtle cortex reveal obvious similarity in
their connections and function to special areas in mammalian
isocortex [39,40], and the types of neurons found in turtle dorsal
cortex (their morphology and neurotransmitter content) also show
great similarity to those observed in mammals [40]. Furthermore,
the chelonian reptile show two phases of sleep (quiet sleep phase
and active sleep phase), which are respectively similar to slow wave
sleep and rapid eye movement sleep in birds and mammals [35].
Large amplitude, arrhythmic spikes were reported to be a
common attribute of the EEG of reptiles and some amphibians
[41]. Generally, they were described in the association with
behavioral quiescence (neck and limbs relaxed, eyes closed) or
sleep [41]. In our study, after 2 mMo r2 0mM MDA treatment,
the EEG pattern shows the conversion from high frequency-low
amplitude to low frequency-high amplitude. The EEG pattern of
low frequency-high amplitude is similar to the sleep phase EEG of
the reptile [35,41]. After 20 mM MDA treatment, the EEG of the
turtles further shows an almost complete suppression of EEG
signal and the appearance of arrhythmic spikes. EEG analysis
reveals statistical changes of power density in all 4 frequency bands
(Figs. 1, 2 and Tab. 1). From 5 minutes to 35 minutes after MDA
treatment, the power density of slow waves (theta wave and delta
wave) increase faster than fast waves (beta wave and alpha wave).
Heart rate of the turtles is significantly lower than that before
treatment. As to the behaviors, after 20 mM MDA treatment, the
turtles showed behavioral quiescence, with their neck and legs
relaxed and extended from the shell, their heads rested on the
Figure 4. The comparison of threshold potentials of sequential spikes (DVts) and the absolute refractory periods (ARP). The
threshold potentials (Vts) of IN and PN before and after 20 mM MDA treatment were shown in panel a and c. The membrance potentials were as
indicated in panel b. DVts were presented in panel d (* p,0.05, **p,0.01).
doi:10.1371/journal.pone.0015325.g004
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stimuli became significantly high. The changes of both the EEG
and the behavior associated with behavioral quiescence or sleep
and imply that the turtle CNS is suppressed [42].
We attempt to simulate the accumulated state of MDA in the
turtle’s brain, so the MDA concentration used in our study is
higher than the normal concentration in the turtle’s body. MDA
was injected intrathecally into the spinal cavity of the turtle and
entered the CNS via the cerebral-spinal circle. Following
continuous accumulation of MDA, the MDA concentration
increased continuously in the brain. The MDA end-concentration
in the turtle’s brain is examined. The MDA end-concentrations of
20 mM group (35 minutes), and 2 mM group (35 minutes) are
respectively higher than that of time-matched control group
(p,0.001), and are respectively 2.40 folds, and 1.89 folds of the
effectual MDA concentration (20 mM) in whole-cell recordings.
The level of GABA increased relatively faster than that of Glu,
and the [GABA]/[Glu] increased. About 5 minutes after the
treatment, the MDA concentration in the brain reached 20 mMo r
more, the cerebral neurons (both the pyramidal neurons and
interneurons) become more excitive. Further excitation of the
cerebral neurons promoted the release of GABA and Glu. From 5
minutes to 35 minutes after 2 mMo r2 0mM MDA treatment,
GABA and Glu contents increased continuously. That is to say,
the balance between the excitatory and inhibitory neurotransmit-
ters was changed. In this period, the turtles’ CNS was under a
relative suppression state since the suppressed EEG was recorded.
Following the metabolism of MDA in the turtle’s brain, the MDA
concentration decreased gradually, and the excitability of the
cerebral neurons also decreased. So the levels of GABA and Glu
also decreased and the balance between the excitatory and
inhibitory neurotransmitters got back gradually. The turtles’ CNS
came back from the relative suppression state. The EEG also
gradually came back to the basal condition from 35 minutes to 60
minutes after MDA treatment (not shown).
Glu and GABA is respectively the most important one of
excitatory and inhibitory amino-acid neurotransmitters in the
mammalian brain, and both of them play key roles in the sleep-
wakefulness cycle [43,44]. They are involved in accomplishment of
critical functions in the reptile’s brain [45]. The concentration ratio
of [GABA]/[Glu] or vice versa [Glu]/[GABA] is usually used as an
objective index to evaluate the CNS state. The MDA accumulation
in the turtle’s brain may change the balance among the
neurotransmitters, so as to cause protective responses of the brain.
As shown by HPLC analysis, in the period from 5 to 35 minutes
after 20 or 2 mM MDA treatment, [GABA]/[Glu] increased
statistically. It appears that the activity of the turtle brain is
relatively suppressed because GABA increases faster than Glu. A
number of studies reported that after sleep deprivation or excessive
exercise, in which free radicals and unsaturated carbonyls appear
largely, not only Glu and GABA but also other neurotransmitters
may be protectively increased [43,46,47,48]. Wang and coworkers
[49] have reported that both the GABA contents and the ratio
[GABA]/[Glu]showanincreaseinallthe3 examinedbrainregions
(the frontal cortex, hypothalamus and brain stem) of the rats in 72 h
sleep deprivation group (p,0.01) than those of control group. The
Figure 5. HPLC analysis of Glu and GABA content in turtles’ brain under MDA treatment. Chromatograms were recorded in 5 minutes
(panel a) and 35 minutes (panel b), under 20 mM MDA treatment. Then, chromatograms were recorded in 35 minutes under the treatment of 2 mM
MDA (panel c); 0.2 mM MDA (panel d); and the phosphate buffer as control (panel e). The HPLC peak area was estimated to calculate the ratio of
[GABA]/[Glu] from the brain extract of turtles at different time intervals under the MDA and control treatments (panel f).
doi:10.1371/journal.pone.0015325.g005
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(p,0.05). Furthermore, as described [50], the contents of GABA in
the cerebral tissue increase 15% under sleep state than that under
consciousness state.
In terms of the mechanisms underlying the dysfunctions of
cerebral neurons in brain networks by MDA from carbonyl stress,
we tested our hypothesis that MDA initiates imbalances between
GABA and glutamate activities, which break down the network
neurons. In HPLC assay, we found that the levels of GABA in brain
tissue treated by MDA were higher than those of glutamate. As
these two neurotransmitters are released from interneurons and
pyramidalneurons,the predominant increaseinGABA level during
MDA treatment may be caused by more excited interneurons. In
examining the excitability in these two types of cerebral neurons, we
observed that the attenuation of threshold potentials is more
dominant in interneurons than pyramidal neurons. The more
sensitivity of interneurons grants them releasing more GABA.
Therefore, we propose that MDA elevation during carbonyl stress
may suppress brain functions through breaking homeostasis
between GABAergic and glutamatergic activities.
Mechanisms underlying MDA-induced sleep-like EEG and
fatigue-like behaviors are likely due to neurons’ dysfunction in
cerebral cortex, which have been examined by patch clamp
technique. In whole-cell recording, we found that MDA prolongs
the refractory periods of sequential spikes mediated by voltage-
gated sodium channels, and in turn inter-spike intervals, i.e.,
decrease a capacity of encoding action potentials, at cerebral
interneurons and pyramidal neurons. The dysfunction of pyrami-
dal cells causes fatigue-like behaviors, and the dysfunction of
interneurons further weakens the encoding ability of pyramidal
neurons (**) and sleep-like EEG.
Several studies demonstrated that neurotoxic 4-hydroxy none-
nal inhibited various enzymes critical for the survival of neurons
such as Na
+-K
+ ATPase [51,52] and glutamate transporters [53].
The suppression of Na
+-K
+ ATPase could induce the slowing
EEG, since the enzyme is the rate-limiting enzyme in determining
EEG frequency [54]. So we speculate that the suppression of EEG
signal also correlates with the interaction of MDA with critical
proteins on the neuronal membrane. In addition, if reagents which
block MA action could be shown to neutralize this response that
would also significantly strengthen this work. To find some proper
blockers and clarify the mechanism of these phenomena, further
studies need to be done.
In summary, we found an attractive phenomenon that MDA
triggered remarkable cerebral suppression of red-eared turtle and
caused sleep-like EEG, and demonstrated that the turtle’s brain
has a stronger ability of anti-carbonyl stress than the mammal.
According to the results, we further propose that similar
phenomena should also appear when carbonyls are accumulated
in mammalian brain, including the human being’s.
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